Literature DB >> 28715922

DLK1-DIO3 imprinted locus deregulation in development, respiratory disease, and cancer.

Jhon R Enterina1, Katey S S Enfield1, Christine Anderson1, Erin A Marshall1, Kevin W Ng1, Wan L Lam1.   

Abstract

INTRODUCTION: The imprinted DLK1-DIO3 locus at 14q32.1-32.31 holds biological significance in fetal development, whereby imprinting errors are causal to developmental disorders. Emerging evidence has implicated this locus in other diseases including cancer, highlighting the biological parallels between fetal organ and tumour development. Areas covered: Controlled regulation of gene expression from the imprinted DLK1-DIO3 locus at 14q32.1-32.31 is crucial for proper fetal development. Deregulation of locus gene expression due to imprinting errors has been mechanistically linked to the developmental disorders Kagami-Ogata Syndrome and Temple Syndrome. In adult tissues, deregulation of locus genes has been associated with multiple malignancies although the causal genetic mechanisms remain largely uncharacterised. Here, we summarize the genetic mechanisms underlying the developmental disorders that arise as a result of improper locus imprinting and the resulting developmental phenotypes, emphasizing both the coding and noncoding components of the locus. We further highlight biological parallels common to both fetal development and disease, with a specific focus on lung development, respiratory disease, and lung cancer. Expert commentary: Many commonalities between respiratory and developmental defects have emerged with respect to the 14q32 locus, emphasizing the importance of studying the effects of imprinting on gene regulation patterns at this locus in both biological settings.

Entities:  

Keywords:  DLK1-DIO3 locus; Kagami-Ogata syndrome; Temple syndrome; cancer; developmental disorders; fetal development; imprinting; noncoding RNA; respiratory disease; uniparental disomy

Mesh:

Substances:

Year:  2017        PMID: 28715922     DOI: 10.1080/17476348.2017.1355241

Source DB:  PubMed          Journal:  Expert Rev Respir Med        ISSN: 1747-6348            Impact factor:   3.772


  9 in total

1.  Lateral transfer of organophosphate degradation (opd) genes among soil bacteria: mode of transfer and contributions to organismal fitness.

Authors:  Dayananda Siddavattam; Harshita Yakkala; Devyani Samantarrai
Journal:  J Genet       Date:  2019-03       Impact factor: 1.166

2.  Maternally inherited 133kb deletion of 14q32 causing Kagami-Ogata syndrome.

Authors:  Hou-Sung Jung; Stephanie E Vallee; Mary Beth Dinulos; Gregory J Tsongalis; Joel A Lefferts
Journal:  J Hum Genet       Date:  2018-09-19       Impact factor: 3.172

3.  Snail mediates repression of the Dlk1-Dio3 locus in lung tumor-infiltrating immune cells.

Authors:  Svenja Groeneveld; Julien Faget; Nadine Zangger; Etienne Meylan
Journal:  Oncotarget       Date:  2018-08-17

Review 4.  Dysregulation of ncRNAs located at the DLK1‑DIO3 imprinted domain: involvement in urological cancers.

Authors:  Jiangfeng Li; Haixiang Shen; Haiyun Xie; Yufan Ying; Ke Jin; Huaqing Yan; Song Wang; Mingjie Xu; Xiao Wang; Xin Xu; Liping Xie
Journal:  Cancer Manag Res       Date:  2019-01-15       Impact factor: 3.989

5.  MiRNAs from DLK1-DIO3 Imprinted Locus at 14q32 are Associated with Multiple Sclerosis: Gender-Specific Expression and Regulation of Receptor Tyrosine Kinases Signaling.

Authors:  Natalia Baulina; German Osmak; Ivan Kiselev; Ekaterina Popova; Alexey Boyko; Olga Kulakova; Olga Favorova
Journal:  Cells       Date:  2019-02-08       Impact factor: 6.600

6.  miRMap: Profiling 14q32 microRNA Expression and DNA Methylation Throughout the Human Vasculature.

Authors:  Eveline A C Goossens; Margreet R de Vries; Karin H Simons; Hein Putter; Paul H A Quax; A Yaël Nossent
Journal:  Front Cardiovasc Med       Date:  2019-08-08

7.  Epigenetic imprinting alterations as effective diagnostic biomarkers for early-stage lung cancer and small pulmonary nodules.

Authors:  Jian Zhou; Tong Cheng; Xing Li; Jie Hu; Encheng Li; Ming Ding; Rulong Shen; John P Pineda; Chun Li; Shaohua Lu; Hongyu Yu; Jiayuan Sun; Wenbin Huang; Xiaonan Wang; Han Si; Panying Shi; Jing Liu; Meijia Chang; Maosen Dou; Meng Shi; Xiaofeng Chen; Rex C Yung; Qi Wang; Ning Zhou; Chunxue Bai
Journal:  Clin Epigenetics       Date:  2021-12-14       Impact factor: 6.551

8.  Pan-cancer analysis of microRNA expression profiles highlights microRNAs enriched in normal body cells as effective suppressors of multiple tumor types: A study based on TCGA database.

Authors:  Sharif Moradi; Aryan Kamal; Hamidreza Aboulkheyr Es; Farnoosh Farhadi; Marzieh Ebrahimi; Hamidreza Chitsaz; Ali Sharifi-Zarchi; Hossein Baharvand
Journal:  PLoS One       Date:  2022-04-27       Impact factor: 3.240

9.  Reactivation of Multiple Fetal miRNAs in Lung Adenocarcinoma.

Authors:  David E Cohn; Mateus C Barros-Filho; Brenda C Minatel; Michelle E Pewarchuk; Erin A Marshall; Emily A Vucic; Adam P Sage; Nikita Telkar; Greg L Stewart; Igor Jurisica; Patricia P Reis; Wendy P Robinson; Wan L Lam
Journal:  Cancers (Basel)       Date:  2021-05-29       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.